BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22854287)

  • 1. Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-α-reactive CD4 T cells in A/J mice.
    Gangaplara A; Massilamany C; Brown DM; Delhon G; Pattnaik AK; Chapman N; Rose N; Steffen D; Reddy J
    Clin Immunol; 2012 Sep; 144(3):237-49. PubMed ID: 22854287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral myocarditis involves the generation of autoreactive T cells with multiple antigen specificities that localize in lymphoid and non-lymphoid organs in the mouse model of CVB3 infection.
    Basavalingappa RH; Arumugam R; Lasrado N; Yalaka B; Massilamany C; Gangaplara A; Riethoven JJ; Xiang SH; Steffen D; Reddy J
    Mol Immunol; 2020 Aug; 124():218-228. PubMed ID: 32615275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cardiac myosin heavy chain-α-specific CD4 cells by using MHC class II/IA(k) tetramers in A/J mice.
    Massilamany C; Gangaplara A; Chapman N; Rose N; Reddy J
    J Immunol Methods; 2011 Sep; 372(1-2):107-18. PubMed ID: 21782819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.
    Massilamany C; Gangaplara A; Reddy J
    Int J Cardiol; 2014 Dec; 177(2):330-339. PubMed ID: 25449464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
    Huber SA; Feldman AM; Sartini D
    Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel mimicry epitopes for cardiac myosin heavy chain-α that induce autoimmune myocarditis in A/J mice.
    Massilamany C; Gangaplara A; Steffen D; Reddy J
    Cell Immunol; 2011; 271(2):438-49. PubMed ID: 21939961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
    Blyszczuk P; Kania G; Dieterle T; Marty RR; Valaperti A; Berthonneche C; Pedrazzini T; Berger CT; Dirnhofer S; Matter CM; Penninger JM; Lüscher TF; Eriksson U
    Circ Res; 2009 Oct; 105(9):912-20. PubMed ID: 19762681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status.
    Leipner C; Grün K; Borchers M; Stelzner A
    Herz; 2000 May; 25(3):245-8. PubMed ID: 10904846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of myocarditis and dilated cardiomyopathy.
    Cihakova D; Rose NR
    Adv Immunol; 2008; 99():95-114. PubMed ID: 19117533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
    Huber SA
    Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
    Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
    Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
    Leipner C; Borchers M; Merkle I; Stelzner A
    J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
    Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
    Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis.
    Yuan J; Yu M; Lin QW; Cao AL; Yu X; Dong JH; Wang JP; Zhang JH; Wang M; Guo HP; Cheng X; Liao YH
    J Immunol; 2010 Oct; 185(7):4004-10. PubMed ID: 20802148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection.
    He F; Yao H; Xiao Z; Han J; Zou J; Liu Z
    Mol Immunol; 2014 May; 59(1):30-8. PubMed ID: 24462896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models for autoimmune myocarditis and autoimmune thyroiditis.
    Ciháková D; Sharma RB; Fairweather D; Afanasyeva M; Rose NR
    Methods Mol Med; 2004; 102():175-93. PubMed ID: 15286386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of anti-heart antibodies in mice after infection with coxsackie B3 virus.
    Latif N; Zhang H; Archard LC; Yacoub MH; Dunn MJ
    Clin Immunol; 1999 Apr; 91(1):90-8. PubMed ID: 10219259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.
    Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H
    Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocyte responses in CVB3-induced murine myocarditis.
    Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
    Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.